Medically reviewed by Katlein Franca, MD Doctors use a process of elimination to diagnose chronic hives, rather than a single test.The diagnostic process involves determining how long the hives have ...

Higher baseline monocyte counts, along with preserved basophils and low C-reactive protein, independently predict complete remission on anti-IgE therapy for CSU.

Phase 3 trial results show remibrutinib significantly improves complete response rates in patients with 3 types of chronic inducible urticaria.

Medically reviewed by Casey Gallagher, MD CSU is a skin condition that causes hives and swelling lasting six weeks or more.The cause of the condition is often unknown, but in the majority of cases ...

Outside the drug’s current urticaria niche, Novartis is also developing remibrutinib in myasthenia gravis and multiple ...

(BPT) – If you’ve had hives, you know how challenging they can be. But you may not know that there is more than one type of hives, or urticaria, and that treatments are available. A brief episode of ...

Experts emphasize that chronic hives require sustained treatment and management, shifting focus from trigger identification to long-term care.

In a healthy body, mast cells (the “lookout” cells of the immune system) only release histamine when they detect a foreign invader, like pollen or venom. In CSU, these cells dump histamine into the ...

If you're being treated for hives, your physician will want to hear what you think about your treatment. Is it working? Are your symptoms improving, staying the same, or getting worse? You may be ...

Patient also had seemingly unexplained concomitant mild anemia, leukocytosis, and eosinoph ...

Hives, or urticaria, can occur for many reasons, such as exposure to an allergen or a physical trigger, like pressure from tight clothing. It may also indicate an infection or another underlying ...